JANE STREET GROUP, LLC

Holdings History for C4 Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CCCC)

Symbol: CCCC on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		0%	+0%	$1,670,856	874,794	+671,226	+330%	$1.91	Q4 2025
30 Sep 2025		0%	-0%	$451,921	203,568	-289,044	-59%	$2.22	Q3 2025
30 Jun 2025		0%	+0%	$704,435	492,612	+480,035	+3817%	$1.43	Q2 2025
31 Mar 2025		0%	-0%	$20,124	12,577	-140,197		$1.60	Q1 2025
31 Dec 2024		0%	+0%	$549,987	152,774	+83,323	+120%	$3.60	Q4 2024
31 Dec 2024	call		-0%	$0	0	-32,800	-100%	$2.23	Q4 2024
30 Sep 2024		0%	-0%	$395,870	69,451	-62,415	-47%	$5.70	Q3 2024
30 Sep 2024	call	0%	+0%	$186,960	32,800	+32,800	NEW	$5.70	Q3 2024
30 Jun 2024		0%	+0%	$609,221	131,866	+77,752	+144%	$4.62	Q2 2024
31 Mar 2024		0%	-0%	$442,111	54,114	-144,557	-73%	$8.17	Q1 2024
31 Dec 2023		0%	+0%	$1,122,491	198,671	+198,671	NEW	$5.65	Q4 2023
30 Sep 2023			-0%	$0	0	-98,565	-100%	$2.23	Q3 2023
30 Jun 2023		0%	-0%	$271,054	98,565	-2,176	-2.2%	$2.75	Q2 2023
31 Mar 2023		0%	+0%	$316,327	100,741	+100,741	NEW	$3.14	Q1 2023
30 Jun 2022			-0%	$0	0	-20,231	-100%	$2.23	Q2 2022
30 Jun 2022	call		-0%	$0	0	-32,900	-100%	$2.23	Q2 2022
31 Mar 2022		0%	+0%	$491,000	20,231	+20,231	NEW	$24.27	Q1 2022
31 Mar 2022	call	0%	+0%	$798,000	32,900	+16,000	+95%	$24.26	Q1 2022
31 Dec 2021	call	0%	+0%	$544,000	16,900	+16,900	NEW	$32.19	Q4 2021
30 Jun 2021			-0%	$0	0	-5,699	-100%	$2.23	Q2 2021
31 Mar 2021		0%	+0%	$211,000	5,699	+5,699	NEW	$37.02	Q1 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.